Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Neoplasms 3 Colonic Neoplasms 3 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Peritoneal Neoplasms 1 Ornithine Carbamoyltransferase Deficiency Disease 1 Obesity, Morbid 1 Neurologic Manifestations 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Gynecological Cancer 1 Genital Diseases, Female 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23 Radiosurgery 21 Temozolomide 14 Bevacizumab 12 pembrolizumab 10 Specimen Handling 9 Nivolumab 8 Radiotherapy 7 Ipilimumab 7 Magnetic Resonance Imaging 6 Cyclophosphamide 5 Capecitabine 5 Blood Specimen Collection 5 encorafenib 4 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Memantine 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 binimetinib 3 abemaciclib 3 Watchful Waiting 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × Laparoscopy × Clear all

NCT06899516 2025-04-03

MILANO

Centre Hospitalier Universitaire de Saint Etienne

Brain Neoplasms, Neoplasms, Neurologic Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡